Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT05150535
Eligibility Criteria:
Inclusion Criteria:
* Female patients 45 years of age or older who have had Oncoplastic Breast Surgery (OBS) or total mastectomy with adequate axillary clearance and a negative margin.
* Breast carcinomas that is invasive (TXN1-3M0, T0N2-3 M0, T1N2-3M0, T2N2-3M0, T3N0-3M0, T4N0-3M0) whatever type of tumors biology.
* All patients with locally advanced breast cancer who received neoadjuvant chemotherapy and underwent either oncoplastic breast surgery or modified radical mastectomy
Exclusion Criteria:
* Metastatic breast cancer at the time of diagnosis proved clinically or radiologically.
* Postoperative positive margin.
* Carcinomas in situ.
* Mesenchymal breast lesions.
* Locoregional recurrent breast cancer.
* Synchronous bilateral breast cancer.
* very early breast cancer (T1-2N0M0,T1N1M0).
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
45 Years
Maximum Age:
85 Years
Study:
NCT05150535
Study Brief:
Protocol Section:
NCT05150535